Idexx Laboratories (IDXX) Other Non-Current Liabilities (2009 - 2026)

Idexx Laboratories' Other Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $54.0 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 13.21% year-over-year to $54.0 million; the TTM figure through Mar 2026 stood at $54.0 million (up 13.21% YoY), while the FY2025 annual figure was $56.5 million, up 27.48% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $54.0 million, down from $56.5 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $71.8 million in Q1 2022, with the low at $44.3 million in Q4 2024.
• The 5-year median for Other Non-Current Liabilities is $62.9 million (2024), against an average of $61.2 million.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities sank 32.33% in 2024, then gained 27.48% in 2025.
• Idexx Laboratories' Other Non-Current Liabilities stood at $67.6 million in 2022, then slipped by 3.05% to $65.5 million in 2023, then tumbled by 32.33% to $44.3 million in 2024, then increased by 27.48% to $56.5 million in 2025, then decreased by 4.41% to $54.0 million in 2026.
• Business Quant data shows IDXX's Other Non-Current Liabilities at $54.0 million in Q1 2026, $56.5 million in Q4 2025, and $57.6 million in Q3 2025.